Purpose The purpose of this study is to summarize recent literature on approaches to supporting healthy coping in diabetes in 2 specific areas: (1) the impact of different approaches to diabetes treatment on healthy coping and (2) the effectiveness of interventions specifically designed to support healthy coping.
Conclusions
Healthy coping in diabetes has received substantial attention in the past 5 years. A variety of approaches show positive results. Research is needed to compare the effectiveness of different approaches in different populations and determine how to overcome barriers to intervention dissemination and implementation. I n recognition of the wide range of coping challenges presented by diabetes across genetic, behavioral, family, social, community, organizational, and political contexts, the American Association of Diabetes Educators (AADE) has identified healthy coping as one of the key AADE7™ Self-Care Behaviors and defined it as the following:
Health status and quality of life are affected by psychological and social factors. Psychological distress directly affects health and indirectly influences a person's motivation to keep their diabetes in control. When motivation is dampened, the commitments required for effective self-care are difficult to maintain. When barriers seem insurmountable, good intentions alone cannot sustain the behavior. Coping becomes difficult and a person's ability to self-manage their diabetes deteriorates.
From this definition, it is clear that the construct of "healthy coping" includes a number of related but distinct domains of psychosocial outcomes. In addition to avoiding specific psychological problems such as depressive and anxiety disorders, high levels of perceived stress and other negative emotions, and diabetes-specific distress, healthy coping also involves positive attitudes toward diabetes and its treatment, positive relationships with others, and high perceived health-related quality of life (QOL). That is, healthy coping extends beyond the mere avoidance of psychiatric morbidity to encompass high levels of psychosocial functioning and a positive outlook on the illness and overall QOL. Table 1 provides more detail on specific healthy coping domains that are commonly examined in the diabetes literature.
As awareness of the interrelationships between diabetes, its management, and these outcomes has grown, interest in intervening to facilitate healthy coping in diabetic patients has also expanded. The purpose of this article is to systematically review literature on healthy coping in diabetes published in the past 5 years, with a focus on identifying evidence for effective interventions that has emerged since a prior review. 1 Two questions Table 1 Domains of Healthy Coping
Domain Description
Depression Disorder of mood characterized by feelings of sadness or emptiness, reduced interest in activities, sleep disturbances, loss of energy, difficulty concentrating or making decisions 83 
Anxiety disorder
Disorders characterized by abnormal or inappropriate symptoms of anxiety (eg, increased heart rate, tensed muscles, intense worry), such as generalized anxiety disorder or panic disorder 83 Perceived stress Degree to which individuals perceive different aspects of their lives as unpredictable, uncontrollable, and overwhelming 84 
Diabetes-specific distress
Negative emotional responses and perceived burden related to diabetes 85, 86 Positive attitudes and beliefs about the illness and treatment Psychological adjustment to diabetes 87 ; treatment satisfaction 88 Positive relationships with others High perceptions of general and diabetes-specific social support; family functioning Health-related quality of life Subjective evaluation of overall physical, mental, and social health and functioning within this broad topic area are addressed: How do different diabetes treatment approaches affect healthy coping outcomes? How do different interventions designed to improve healthy coping affect psychosocial and QOL outcomes?
Methods

Search
Parallel with the multiple domains of healthy coping, intervention approaches for addressing concerns in diabetic patients across the life span are diverse, and there are relatively few well-controlled studies of any single intervention approach. Thus, this review was designed to provide a broad appraisal of promising approaches for addressing an array of healthy coping issues. The review used systematic review procedures in specifying the terms and approach to searching for and abstracting data from articles but used narrative procedures in including articles without a priori criteria based on methods and design.
A PubMed search of the English-language literature published between August 1, 2006 , and April 30, 2011, was performed. Combinations of diabetes with the terms emotion, quality of life, depression, adjustment, anxiety, anxious, coping, family therapy, behavior therapy, psychotherapy, problem solving, couples therapy, or marital therapy were used to identify relevant studies. Figure 1 provides details on search procedures and results.
Study Selection
Titles and abstracts of articles meeting the above search criteria were reviewed as candidates for data -PubMed (www.pubmed.gov) search (May 19, 2011) for (1) diabetes in MESH terms and (2) cognates of emoƟon or quality of life or cognates of depression or adjustment or anxiety or anxious or coping or family therapy or cognates of behavior with therapy or cognates of psychotherapy or problem solving or couples therapy or marital therapy in fields of Ɵtle or abstract.
ArƟcles limited to English language and publicaƟon between August 1, 2006 abstraction. To be included in the final review, articles needed to report the effects of either a diabetes treatment or healthy coping intervention on at least 1 psychosocial or QOL outcome. Retrospective and prospective studies were included, along with narrative or systematic review articles. All articles pertaining to type 1 diabetes (T1DM) or type 2 diabetes (T2DM) were included, and there were no restrictions with regard to patient age. Articles aimed at lay audiences, statements of opinion, or descriptions of programs with no research component were excluded.
Data Abstraction
Articles meeting criteria were grouped into the 2 main questions targeted for review: (1) evidence describing the impact of diabetes treatments on healthy coping constructs and (2) interventions to promote healthy coping. Articles were then further categorized according to intervention type (see Figure 1 ), abstracted independently by the authors, and incorporated into the Healthy Coping Evidence Table (available as an online appendix) . Abstracted data elements included study design, original research versus review of published studies, study objectives, sample size, healthy coping outcomes assessed, other outcomes assessed (eg, A1C), and principal findings, including both significant and nonsignificant results. For all studies, the American Association of Clinical Endocrinologists (AACE) evidence ratings 2 corresponding to the study designs were also determined.
Study Characteristics
As shown in Figure 1 , 129 articles met criteria for inclusion, including 59 articles examining the effect of diabetes treatments on healthy coping domains and 70 articles examining the efficacy or effectiveness of interventions specifically designed to promote healthy coping. Cognitive behavior therapy, family therapy, diabetes self-management education, and primary care-based approaches were the most common intervention types; fewer articles were identified that focused on problem solving and coping skills, support groups or group counseling, and medication for psychological problems.
Data Synthesis
The evidence table describing studies within the 2 broad areas relevant to healthy coping in diabetes drove the organization of the narrative review accordingly: (1) effect of diabetes treatments on QOL and psychosocial outcomes and (2) evidence for the efficacy or effectiveness of healthy coping interventions in improving QOL and other psychosocial outcomes. Results summarized in the text below focus on articles reporting original research, with Tables 2 and 3 providing additional detail in 2 areas. Table 2 summarizes the large number of studies that examined the psychosocial and QOL effects of different methods of intensifying treatment in poorly controlled diabetes, whereas Table 3 summarizes original intervention research studies identified in the review. The complete Healthy Coping Evidence Table is available as an online appendix.
Results
Part 1: Impact of Diabetes Treatments on Quality of Life
A total of 45 original research studies and 14 review articles were identified that examined psychosocial and QOL outcomes of different diabetes treatment approaches. One of the most active areas of research suggests mostly, but not entirely, 3 positive effects of continuous subcutaneous insulin injection (CSII; ie, insulin pump therapy) relative to multiple daily injections (MDIs) on treatment satisfaction, emotional health, and QOL in youth with T1DM, 4-9 their parents, 5,10-12 and adults with T1DM. 13, 14 Although only the Opipari-Arrigan 11 study involving preschoolers with T1DM and their parents used a randomized controlled design, the remaining observational studies have the advantage of increased generalizability to realworld shared decision making about treatments (ie, for patients who elect to use the pump, coping and QOL tend to improve). Insulin pump use in T2DM has been studied much less frequently. One study 15 showed improved QOL and treatment satisfaction in patients switching from injections to CSII but no effect in patients previously taking oral hypoglycemic agents (OHAs) only; another study 16 reported no overall QOL differences for CSII versus MDI. Other treatment advances such as inhaled insulin, 17,18 continuous glucose monitoring, [19] [20] [21] continuous intraperitoneal insulin infusion, 22 pancreatic-kidney 23 and islet cell 24 transplantation, and supplemental metformin therapy 25 in T1DM have demonstrated positive QOL impacts, but small numbers of studies and observational designs prohibit any firm conclusions.
Another active area has been how to intensify treatment in T2DM in a way that maximizes QOL when initial lifestyle changes and OHAs fail to adequately Compare diabetes-related distress and clinical outcomes in type 2 diabetic patients using insulin with or without mealtime pramlintide (an amylin analog)
Randomized, double-blind, placebo-controlled study; type 2 patients using insulin glargine with or without OHAs were randomized to pramlintide or placebo.
N = 211
Pramlintide use resulted in decreases in total diabetes-related distress and regimen-related distress in those who were highly distressed at baseline.
Peyrot et al 2010 28
Assess effect of adding mealtime pramlintide or RAIA to basal insulin therapy in patients with uncontrolled type 2 diabetes.
Open-label, randomized, parallel group trial, stratified with regard to use of basal insulin prior to study enrollment.
N = 112
Adding either pramlintide or RAIA at mealtime to basal insulin improved treatment satisfaction. Pramlintide also reduced diabetes distress and improved sleep quality, weight control, and appetite control; RAIA improved eating flexibility and perceived weight control. Bode et al 2010 29 Compare effect of adding a GLP-1 once-daily medication (liraglutide) vs an OHA (glimepiride) to treatment regimen.
Randomized, double-blind, double-dummy, parallel-group, multicenter clinical trial; patients stratified by initial treatment with a single OHA vs diet and exercise only and randomized to once-daily treatment with once-daily liraglutide (GLP-1) 1.2 mg or 1.8 mg or glimepiride (sulfonylurea).
N = 732
Liraglutide produced more favorable improvements in health-related QOL and weight concerns compared with glimepiride, with much stronger effects at the higher dosage of 1.8 mg.
(continued) control blood glucose. As evidenced by studies listed in Table 1 26-33 -all of which consisted of randomized controlled trials-treatment intensification in patients with poor glycemic control (eg, >9.0%) typically improves both QOL and treatment satisfaction. In addition, there appears to be evidence of greater benefits when insulin or newer injectable agents (glucagon-like peptide [GLP] agonists and analogues, amylin analogues) are added to Randomized, open-label, parallel-group, multicenter trial.
N = 308
The insulin regimens improved QOL and treatment satisfaction similarly to a multiple drug oral regimen.
Lingvay et al 2009 31
Compare triple therapy with OHA (metformin, pioglitazone, and glyburide) to twice-daily insulin plus metformin in newly diagnosed, adult type 2 diabetic patients.
Open-label, randomized controlled trial.
N = 29
There were no group differences in hypoglycemic events, weight gain, adherence, or changes in QOL, and social worries improved over time in both groups. All patients assigned to insulin reported satisfaction with insulin treatment and willingness to continue at 18 months follow-up.
Houlden et al 2007 32
Assess effect of insulin glargine (basal insulin) initiation with no change in OHA therapy vs optimization of OHA therapy on QOL.
Randomized, controlled trial of adults aged 18-80 with type 2 diabetes and inadequate glucose control taking 0, 1, or 2 OHAs.
N = 366
Addition of insulin glargine vs more OHAs had greater positive impact on treatment satisfaction and QOL.
Vinik and Zhang 2007 33
Compare effect of add-on insulin glargine vs rosiglitazone on health-related QOL in patients with type 2 diabetes already taking a sulfonylurea plus metformin.
24-week, multicenter, randomized, open-label, parallel-group trial.
N = 217
Symptom distress, mood symptoms, ophthalmologic distress, fatigue distress, and general self-rated health improved more for the insulin glargine group. Adverse events were also less frequent in the insulin glargine group.
Abbreviations: GLP, glucagon-like peptide; OHA, oral hypoglycemic agent; QOL, quality of life; RAIA, rapid-acting insulin analog. 
Summaries of Key Intervention Articles
Reference Study Objectives and Methods
Study Design
Sample Size
Findings
Diabetes Self-Management Education
Speight et al 2010 42 Evaluate long-term (44-month follow-up) outcomes of DAFNE, a structured education program in intensive insulin therapy for adults with poorly controlled type 1 diabetes.
Observational cohort study of all participants who were originally randomized to receive DAFNE immediately vs after a 6-month wait list.
N = 104
Improvements in QOL seen at 12-month follow-up were sustained at 44-month follow-up. Improvements in treatment satisfaction at 12-month follow-up decreased significantly at 44 months but remained meaningfully higher than baseline levels.
Kempf et al 2010 43 Evaluate ROSSO-in-praxi, a structured 12-week motivation and education program focused on self-monitoring of blood glucose in 405 adults with type 2 diabetes.
Pre-post within-group comparison.
N = 405
Mental health and depressive symptoms improved from pre-intervention to post-intervention.
Rossi et al 2010 41 Compare use of a DID to a structured carbohydrate-counting education program.
Open-label, international, multicenter, randomized parallel-group trial;
adults with type 1 diabetes were randomly assigned to DID vs carbohydrate-counting education.
N = 130
The DID group experienced greater improvements in treatment satisfaction and QOL, including greater dietary freedom, and duration of education required was lower.
Bendik et al 2009 40 Evaluate training in flexible insulin therapy on psychological and metabolic outcomes in type 1 diabetic patients; intervention consisted of 7 weekly group sessions.
Pre-post within-group comparison of type 1 diabetic patients. (Continued)
Reference Study Objectives and Methods
Study Design
Sample Size
Findings
Comellas et al 2010 49 Evaluate peer-led community discussion circles integrating self-management support with discussion of information and skills through storytelling and exercises.
Pre-post within-group comparison of urban, minority adults with diabetes.
N = 17
Improved some aspects of well-being, including feeling more active and vigorous at program completion.
Problem-Solving and Coping Skills
Amoako (Continued)
Reference Study Objectives and Methods
Study Design
Sample Size
Findings
Snoek et al 2008 57 Compare CBT delivered in a group format to BGAT in adults with poorly controlled type 1 diabetes, and examine whether effects varied by baseline depression. adolescents with poorly controlled diabetes.
N = 10
Pre-post differences in diabetes-related stress and concerns about self-care in social situations were not significant, but there was a trend toward improvement in concerns about self-care in social situations.
Monaghan et al 2011 55 Evaluate feasibility and initial efficacy of a telephone intervention based on social cognitive theory and incorporating cognitive-behavioral techniques for parents of young children with type 1 diabetes.
Randomized trial (treatment vs wait-list control group); initial analyses were for pre-post changes in the 14 parents assigned to the initial treatment group.
N = 14
Parenting stress and perceived social support improved for parents after participating in the intervention.
Family Therapy
Harris et al 2009 61 Evaluate a 10-session, home-based BFST for adolescents with poorly controlled type 1 diabetes.
Pre-post evaluation with normative outcome comparison using data from adolescents with poor diabetes control included in a previous study.
N = 58
The BFST intervention decreased diabetes-related family conflict by 1/3 to 1/2 of a standard deviation, and general family conflict decreased from 
N = 87
Depressive symptoms, QOL, and pain all improved in both the sertraline and placebo groups, with no significant differences between groups.
Williams et al 2007 65
Examine effect of sertraline maintenance therapy on time-to-recurrence of major depressive disorder in younger vs older adults with diabetes.
52-week follow-up of patients achieving depression recovery after participating in a randomized, double-blind, placebo-controlled trial.
N = 152
In younger patients, sertraline yielded significantly greater protection against depression recurrence than placebo, but there was no difference in recurrence for older patients treated with sertraline vs placebo.
Other Interventions
Beever et al 2010 70 Evaluate effect of 3-times weekly, 20-minute far-infrared sauna treatments on QOL in adults with type 2 diabetes.
Physical health, general health, social functioning, stress, and fatigue improved from pre-intervention to post-intervention.
Skoro-Kondza et al
2009 71 Evaluate community-based yoga classes for adults with type 2 diabetes.
Randomized trial; adults with type 2 diabetes (not on insulin) were randomized to participate in twice-weekly, 90-minute yoga classes for 12 weeks or wait-list control group.
N = 59
The rate of ineligible patients was high, largely due to insulin treatment or contraindications to yoga (eg, ischemic heart disease, cerebrovascular disease), as was the rate of refusal due to lack of interest. The attendance rate at class was 50%. Intent-to-treat analyses showed no significant effects on QOL or self-efficacy. Bicenter, open-label, randomized, 2-period, crossover 12-month study; adults with type 1 diabetes on pump therapy assigned to intervention or wait-list control.
N = 30
QOL improved significantly more in the intervention group, and 76% of patients felt that the quality of their medical care was higher during the intervention period.
Approaches in Primary Care
Ell et al 2010 74 Compare effectiveness of collaborative depression care vs usual primary care in older vs younger adults with chronic physical illnesses, including diabetes, cancer, and others.
Pooled, intent-to-treat analyses of 3 randomized controlled trials of collaborative depression care consisting of choice of first-line depression therapy (psychotherapy, medication, or both) and a structured algorithm for stepped care.
N = 1081
Both younger and older patients experienced a significant improvement in depressive symptoms and major depression rates at 6-month follow-up, with no difference in effectiveness by age group. Cross-sectional study; patients attending a diabetes care clinic were screened for depression by a student pharmacist, who then abstracted additional information from their chart.
N = 45
The student pharmacist's screening suggested that 75% of patients with previously diagnosed depression were being inadequately treated and 48% of patients with no prior depression diagnosis had significant depressive symptoms.
Goss et al 2010 76 Evaluate a new, interdisciplinary model of rural pediatric diabetes care called RADICAL, which involved a co-located team of pediatrician, diabetes educator, and mental health nurse who regularly met to discuss each patient's care, provided proactive child and family emotional support, and actively attempted to match insulin regimens with the patient's lifestyle.
Pre-post evaluation of children under 21 years old with type 1 diabetes.
N = 61
The RADICAL model resulted in increased patient satisfaction and elimination of a previously documented rural-urban disparity in patient QOL.
Jones et al 2006 97
Compare receipt of adequate antidepressant dosing and duration of therapy in veterans with vs without diabetes.
Retrospective cohort study of patients of a midwestern Veterans Affairs facility, including those with comorbid diabetes.
N = 2332
In depressed veterans, dosing of antidepressants was adequate but treatment duration often fell short. A diabetes diagnosis did not adversely affect antidepressant treatment quality.
Abbreviations: ACT, acceptance and commitment therapy; BFST, behavioral family systems therapy; BGAT, blood-glucose awareness training; CBT, cognitive-behavioral therapy; DAFNE, Dose Adjustment for Normal Eating; DID, diabetes interactive diary; DSME/T, diabetes self-management education/therapy; ES, educational support; HMO, health maintenance organization; MET, motivational enhancement therapy; MST, multisystemic therapy; NCM, nurse case management; QOL, quality of life; RPS, reciprocal peer-support; SMBG, self-monitoring of blood glucose; TBT, telehealth behavioral therapy. Table 3 (Continued) the patient's medication regimen versus adding another OHA (eg, adding sitagliptin or pioglitazone to metformin only). This research, along with studies documenting high prevalence of side effects associated with OHAs, 34, 35 suggests that insulin, and particularly insulin analogues, [36] [37] [38] or other injectable agents may be preferred over complex OHA regimens in T2DM patients. Table 2 summarizes key original research studies published in the past 5 years that evaluate interventions in terms of their effects on QOL and/or other psychosocial outcomes.
Part 2: Interventions to Promote Healthy Coping
Several studies were identified that found diabetes self-management education (DSME) to improve QOL [39] [40] [41] [42] and other psychosocial and emotional outcomes, such as depressive symptoms 43 and treatment satisfaction, 42 although in some cases, beneficial healthy coping effects were short-lived 44 or not observed. 45, 46 It is notable that of the 5 interventions in this category demonstrating positive effects, 4 focused on self-managing insulin in conjunction with diet for insulin-dependent and primarily T1DM patients. [39] [40] [41] [42] The only intervention targeted at patients with T2DM that showed positive effects focused on self-monitoring of blood glucose and patient motivation but did not use a randomized, controlled design. 43 This pattern of results suggests that QOL and other psychosocial outcomes in T2DM may require more intensive or coping-focused efforts beyond DSME.
Several studies suggested promising effects of adult patients' participation in diabetes support groups in diverse settings, including 2 well-designed, randomized controlled trials. 47, 48 In the first trial, improved QOL in 4 domains (physical health, psychological health, social participation, and environment) was observed among Thai patients participating in a 16-week self-help group. 47 In the second trial, improved perceptions of social support and willingness to initiate insulin were observed among male veterans participating in a reciprocal peer support program with supplemental group sessions, although diabetes-related distress was not significantly different across groups. 48 Finally, a small pilot study demonstrated improved activity and vigor levels in urban, minority adults participating in peer-led community discussion circles, although it did not elicit significant changes in other aspects of well-being. 49 The diversity of the patient populations across these 3 studies suggests that the use of peer support may be a strategy that is potentially robust across patient subgroups, at least among adults. However, the few peer support studies identified overall, the lack of studies in youth with diabetes, and heterogeneity in the specific psychosocial outcomes assessed highlight the need for more research to understand the full potential of peer support in facilitating healthy coping.
Recent studies also provide evidence for the efficacy of problem-solving and coping skills interventions when delivered to adults with T2DM. One randomized controlled trial showed that a 4-week problem-solving and cognitive reframing, telephone-based intervention for older African American women improved psychosocial adjustment and problem solving, reduced uncertainty, and increased participation in physical activity. 50, 51 Another intervention found that increasing one's use of acceptance and mindfulness coping strategies improved diabetes self-care. 52 These studies suggest that an emphasis on problem solving may benefit psychosocial outcomes in addition to self-care behavior and glycemic control, although more studies evaluating a common set of healthy coping outcomes are needed in this area as well.
There has been substantial interest in cognitive behavioral therapy (CBT), including several studies suggesting effectiveness of CBT-based interventions on depressive symptoms and diabetes-related stress, when delivered via novel formats, such as the Internet and/or telephone. [53] [54] [55] However, evidence from recent trials is mixed, with some suggestion of less favorable results when these interventions are delivered to youth and/or youth-parent dyads 54, 56 compared with parents alone 55 or adult patients. 53, [57] [58] [59] In addition, a recent randomized trial of group CBT suggests that CBT may be most helpful for patients who are experiencing higher versus lower levels of depressive symptoms. 57 A recent review of interventions for individuals with diabetes and depression also noted the greatest improvements in depression for CBT compared with other psychotherapeutic or pharmacological approaches. 60 Several studies of family therapy approaches applied to youth with T1DM and their families have produced good evidence of positive initial impacts on family conflict 61, 62 and interaction, 63 adherence, 62 and problem solving. 63 The methodological quality of these studies was high, with 3 of these 4 studies using randomized controlled designs comparing family therapy to usual care and/or education support. No family therapy interventions were identified for adults with either T1DM or T2DM, a major oversight in the literature.
Additional evidence for the efficacy of sertraline in reducing depressive symptoms among adult patients, as well as improving QOL and pain, was found in one randomized, double-blind, controlled trial that involved lowincome minority patients with diabetes and comorbid depression. 64 However, another trial 65 of the ability of sertraline to prevent recurrence of major depressive disorder in diabetic patients achieving initial depression recovery found evidence of efficacy only in younger patients, suggesting that nonmedication approaches with older adults may be more appropriate. A notable gap in the literature is the absence of studies examining the use of antidepressant medication in conjunction with or in comparison with nonpharmaceutical, guidelinerecommended 66 depression therapies (eg, CBT, problemsolving therapy).
Other promising intervention approaches identified in the past 5 years via relatively small pilot studies include supportive psychotherapy for adults with comorbid depression, 67 intensive multitherapy for improving QOL and self-care behavior, 68 telemedicine support using short-messaging service (ie, texting) for improving QOL, 69 and far-infrared sauna treatments for improving physical health, general health, social functioning, stress, and fatigue. 70 Larger, randomized trials of these approaches are warranted. There has also been interest in the utility of yoga classes for improving QOL, but one randomized trial found difficulties in implementing such classes and no impact on QOL. 71 There has been considerable interest in developing and evaluating approaches to support healthy coping in the delivery of primary care: for example, collaborative care interventions for comorbid depression in diabetic patients. Recent findings support the long-term maintenance of effects of collaborative care on depression 72, 73 and its effectiveness when applied to both younger and older patients 74 as well as public safety-net clinics serving primarily low-income, Hispanic adults with diabetes. 75 Other research supports the utility of the RADICAL model for eliminating rural-urban disparities in QOL among pediatric diabetic patients, which implements a co-located team consisting of a pediatrician, diabetes educator, and mental health nurse who meet regularly to discuss each patient's care and provide preferencematched therapy and emotional support to children and their families. 76 Additional research has demonstrated the feasibility of employing pharmacy students in a pharmacist-managed diabetes clinic to improve the identification of comorbid depression in diabetic patients. 77 Thus, innovative care models that integrate mental health care into traditional diabetes care settings appear to be a feasible and effective way of supporting healthy coping across different patient populations.
Discussion, Conclusions, and Implications
Findings from studies published in the past 5 years, and particularly the recent proliferation of articles examining psychosocial impacts of different diabetes treatments, suggest growing appreciation within the medical and research communities of the complex relationships between diabetes treatment, psychosocial factors, and metabolic control and the importance of explicitly considering QOL effects when treating diabetic patients. The findings are also encouraging in that they suggest that there is much that diabetes educators and other health care providers can do to improve coping, emotional health, and QOL in their patients:
• Treatment intensification in response to poor metabolic control often improves both clinical and QOL outcomes. • Type of diabetes treatment may have a large impact on QOL and other psychosocial outcomes, suggesting that regimen changes in light of high levels of distress and/or low healthrelated QOL should be considered and discussed with patients. A wide range of instruments are available for assessing psychosocial and QOL effects of diabetes and its treatment, as described previously. 1 • Use of CSII in T1DM and other intensive therapies in diabetes generally, as well as earlier initiation of insulin and/or minimizing complexity of OHA regimens in T2DM diabetes specifically, can elicit improved emotional health and QOL. • A variety of intervention approaches for enhancing healthy coping continue to show positive results, providing educators and program planners an opportunity to choose and implement options based on the needs and preferences of their patients and available resources. • With regard to the treatment of comorbid depression, CBT and collaborative care interventions have elicited some of the strongest supportive evidence for effectiveness in realworld settings.
From these conclusions, a broad pattern emerges of considerable importance. It seems now well established that for a range of tactics and approaches to enhancing quality of diabetes care, better control of diabetes leads to better QOL. Given the frequency of multiple comorbidities in diabetes, clinicians may be hesitant to complicate regimens in a manner that places too great a burden on patients. Also, it has long been recognized that adherence is compromised by complexity of treatment regimens. 78 Nevertheless, it appears that enhancing the intensity of treatment when glycemic control is poor is typically associated not so much with greater experienced burden and distress but with feeling better.
Research Gaps
As the number and heterogeneity of medical treatments for controlling blood glucose in diabetes continue to expand, there remains an ongoing need for research comparing the effect of these different options on healthy coping outcomes. This research should examine the possibility that psychosocial and QOL effects of different treatments may vary across subpopulations, reflecting the different needs and unique circumstances of these groups. For example, the effects of treatment intensification on QOL among older, frail adults with multiple comorbidities may be very different than among those in their 40s or 50s whose principal medical problem is diabetes. Thus, there is a need for additional research comparing the effect of different diabetes treatment regimens on healthy coping outcomes in the growing population of older, frail diabetic patients with multiple comorbidities. This is of critical importance given that in older, frail patients, medicationrelated problems, adverse events, and risk of hypoglycemia are much more common and that minimizing treatment burden for patients and caregivers is of greater concern compared with intense glycemic control. [79] [80] [81] As noted above, there is at least preliminary evidence supporting the efficacy and/or effectiveness of a number of diverse intervention approaches to directly targeting coping outcomes in diabetic patients. The downside of these multiple options is that diabetes educators may be uncertain as to which options may produce the best outcomes in their patient populations. There is a need to conduct head-to-head comparisons of different approaches identified in this review for directly targeting coping outcomes in diabetes with varying amounts of evidence for efficacy and effectiveness. In addition, some approaches have very good evidence in specific subpopulations (eg, family therapy for youth with T1DM) but have been virtually untested in other populations where they may be similar useful (eg, older patients with reduced functional independence). Future research should examine the feasibility and effectiveness of adapting such approaches for use with a broader range of patient populations.
Finally, there is a continued need for greater dissemination of approaches identified as efficacious or effective in a particular setting. 1 The greatest challenge remains how to practically translate interventions into routine care so that more patients can benefit. More research into large-scale dissemination methods as well as intervention toolkits and guides is sorely needed. Among existing resources is Healthy Coping in Diabetes: A Guide for Program Development and Implementation. 82 This guide and other materials developed by the Robert Wood Johnson Foundation Diabetes Initiative (http://diabetesnpo.im .wustl.edu/), as well as professional and patient-education materials of the AADE and American Diabetes Association, may be especially helpful for those in the field.
